medigraphic.com
ISSN 1560-4381 (Print)

2015, Number 3

<< Back Next >>

Correo Científico Médico 2015; 19 (3)

Use of propranolol in parotid hemangioma

Quintero DZ, Atienza LL, Sánchez GL

Language: Spanish
References: 16
Page: 565-571
PDF size: 300.82 Kb.


ABSTRACT

The use of the propranolol is a therapeutic alternative in the infantile hemangiomas. The results described in the literature regarding its use place this therapy in one of the first election lines in the treatment of this illness. An infant of four years of age with left parotid hemangioma was reported. The patient was diagnosed and treated in Cienfuegos Pediatric Hospital and did not have a satisfactory response with the steroids, and with the use of propranolol a complete regression of the lesion was observed, keeping the treatment for one year, not presenting any complication with its use.


REFERENCES

  1. Ji Y, Chen S, Li K, Li L, Xu C, Xiang B. Signaling pathways in the development of infantile hemangioma. J Hematol Oncol. 2014 [citado 23 may 2014]; 7(1):13. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913963/

  2. Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008 [citado 15 may 2014]; 122(2):360–367. Disponible en: http://preview.ncbi.nlm.nih.gov/pubmed/?term=Growth

  3. Bentz BG, Anthony Hughes C, Lüdemann JP, Maddalozzo J. Masses of the salivary gland region in children. Arch Otolaryngol Head Neck Surg. 2000 [citado 12 feb 2013]; 126(12):1435–1439. Disponible en: http://preview.ncbi.nlm.nih.gov/pubmed/?term=Masses+of+the+salivary

  4. Zheng JW, Zhang L, Zhou Q, Mai HM, Wang YA, Fan XD, et al. A practical guide to treatment of infantile hemangiomas of the head and neck. Int J Clin Exp Med. 2013 [citado 18 may 2014]; 6(10):851-60. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832322/

  5. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992 [citado 15 feb 2013]; 326(22):1456–1463. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJM199205283262203

  6. Enjolras O, Brevière GM, Roger G, Tovi M, Pellegrino B, Varotti E. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr. 2004 [citado 23 may 2014]; 11(2):99–107. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Pediatr.+2004%3B+11(2)%3A99%E2%80%93107

  7. Patnaik SK, Sondhi V. Treating subglottic haemangioma with methylprednisolone and interferonα-2a. BMJ Case Rep. 2009 [citado 16 may 2014]; 7. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027784/

  8. Neri I, Balestri R, Patrizi A. Hemangiomas: new insight and medical treatment. Dermatol Ther. 2012 [citado 31 may 2014]; 25(4):322-34. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Dermatol+Ther.+2012+Jul-Aug%3B+25(4)%3A322-34.

  9. McSwiney E, Murray D, Murphy M. Propranolol therapy for cutaneous infantile haemangiomas initiated safely as a day-case procedure. Eur J Pediatr. 2013 [citado 13 may 2014]; 173(1): 63-8. Disponible en: http://link.springer.com/article/10.1007%2Fs00431-013-2105-5

  10. Zheng JW. Comment on efficacy and safety of propranolol in the treatment of parotid hemangioma. Cutan Ocul Toxicol. 2011 [citado 13 may 2014]; 30(4):333-4. Disponible en: http://informahealthcare.com/doi/abs/10.3109/15569527.2011.584928

  11. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol. 2010 [citado 31 may 2014]; 163(2):269–274. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.2010.09848.x/abstract

  12. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med. 2008 [citado 14 abr 2014]; 359(26):2846. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMc086443

  13. Reinisch JF, Kim RY, Harshbarger RJ, Meara JG. Surgical management of parotid hemangioma. Plastic and Reconstructive Surgery. 2004 [citado 23 may 2014]; 113(7):1940–1948. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Plastic+and+Reconstructive

  14. Sinno H, Thibaudeau S, Coughlin R, Chitte S, Williams B. Management of infantile parotid gland hemangiomas: a 40-year experience. Plastic and Reconstructive Surgery. 2010 [citado 12 feb 2014]; 125(1):265–73. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Plastic+and+Reconstructive+Surgery.+2010%3B+125(1)%3A265%E2%80%93273.

  15. Weiss I, O TM, Lipari BA, Meyer L, Berenstein A, Waner M. Current treatment of parotid hemangiomas. Laryngoscope. 2011 [citado 23 may 2014]; 121(8): 1642-50. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/lary.21358/abstract

  16. Bagazgoitia L, Torrelo A, Gutiérrez JC, Hernández-Martín A, Luna P, Gutiérrez M, et al. Propranolol for infantile hemangiomas. Pediatr Dermatol. 2011 [citado 13 may 2014]; 28(2): 108-14. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1525-1470.2011.01345.x/abstract




2020     |     www.medigraphic.com